AI assistant
Sending…
Cytosorbents Corp — Director's Dealing 2011
Mar 11, 2011
34501_dirs_2011-03-11_04af324d-1e98-4f44-b1d7-7f95575ac1bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2011-01-21
Reporting Person: Kraus Al (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-01-21 | Stock Option | $0.138 | A | 200000 | Acquired | 2021-01-21 | Common Stock (200000) | Direct |
Footnotes
F1: As compensation for services rendered, on January 21, 2011, Mr. Al Kraus was issued an option to purchase 200,000 shares of
common stock at an exercise price of $0.138 per share which will expire on January 21, 2021.
More from Cytosorbents Corp
Annual Report
2026
Apr 15
Delisting Announcement
2026
Apr 2
Annual Report
2026
Mar 30
Earnings Release
2026
Mar 25
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2025
Nov 21
Earnings Release
2025
Nov 13
Interim / Quarterly Report
2025
Nov 13
Delisting Announcement
2025
Oct 3
Regulatory Filings
2025
Sep 16